IRIS
SCHENONE, ANGELO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 25.673
Totale 25.673
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 25.673
Totale 25.673
Salva come PNG Salva come JPEG
Città #
Genova 20.049
Rapallo 3.110
Genoa 2.421
Bordighera 93
Totale 25.673
Salva come PNG Salva come JPEG
Nome #
Consistence and discrepancy of neuropathic pain screening tools DN4 and ID-Pain. 168
Hereditary motor and sensory neuropathy with myelin outfolding: clinical, genetic and neuropathological study of three cases 149
Experimental Charcot-Marie-Tooth type 1A: A cDNA microarrays analysis 145
Reliability of clinical outcome measures in Charcot-Marie-Tooth disease. 144
Does parkin play a role in the peripheral nervous system? A family report 143
Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial. 143
Autologous stem cell transplantation as rescue therapy in malignant forms of multiple sclerosis. 140
Hereditary motor and sensory neuropathy with deafness, mental retardation and absence of large myelinated fibers. 138
Dysimmune mononeuropathies: A diagnosis not to be missed 137
Relapses after treatment with rituximab in a patient with multiple sclerosis and anti myelin-associated glycoprotein polyneuropathy. 136
Clinical epidemiology of ALS in Liguria, Italy. 136
Sphingomyelin as a myelin biomarker in CSF of acquired demyelinating neuropathies 136
Intense immunosuppression followed by autologous stem cell transplantation in severe multiple sclerosis. 134
Direct immunofluorescence in sural nerve biopsies. 133
17p11.2 duplication is a common finding in sporadic cases of charcot-marie-tooth type 1 133
Underexpression of messenger RNA for peripheral myelin protein 22 in hereditary neuropathy with liability to pressure palsies 132
Peripheral Nerve Society Guideline on processing and evaluation of nerve biopsies. 132
Mycophenolate mofetil in dysimmune neuropathies: a preliminary study. 132
Impairment of central motor conduction in diabetic patients. 131
Sural nerve biopsy and functional studies support the pathogenic role of a novel MPZ mutation. 131
Early abnormalities in sciatic nerve function and structure in a rat model of Charcot-Marie-Tooth type 1A disease. 130
Alterations in the Arf6-regulated plasma membrane endosomal recycling pathway in cells overexpressing the tetraspan protein Gas3/PMP22 129
A novel mutation of GDAP1 associated with Charcot-Marie-Tooth disease in three Italian families: evidence for a founder effect 129
HSPB1 and HSPB8 in inherited neuropathies: study of an Italian cohort of dHMN and CMT2 patients 129
The diadenosine homodinucleotide P18 improves in vitro myelination in experimental Charcot-Marie-Tooth type 1A 129
Autoimmune central diabetes insipidus in a patient with ureaplasma urealyticum infection and review on new triggers of immune response. 129
Natural history of CMT1A including QoL: a 2-year prospective study. 128
Phenotypic characterization of hypomyelination and congenital cataract 128
Mifepristone (RU 38486) influences expression of glycoprotein Po and morphological parameters at the level of rat sciatic nerve: In vivo observations . 126
A novel compound heterozygous mutation ofC20orf54gene associated with Brown-Vialetto-Van Laere syndrome in an Italian family 126
Variables influencing quality of life and disability in Charcot Marie Tooth (CMT) patients: Italian multicentre study. 125
147th ENMC International Workshop: Guideline on processing and evaluation of sural nerve biopsies, 15-17 December 2006, Naarden, The Netherlands. 125
Charcot-Marie-Tooth and pain: correlations with neurophysiological, clinical, and disability findings. 124
High-dose Ig VENA is well tolerated and efficacious in patients with multifocal motor neuropathy 124
Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial. 123
GFAP expression of human Schwann cells in tissue culture. 123
Charcot-Marie-Tooth (CMT) 1a duplication at 17p11.2 in Italian families. 123
Progressive sensory-motor polyneuropathy with tomaculous changes is associated to 17p11.2 deletion. 123
Tolerability and efficacy study of P2X7 inhibition in experimental Charcot-Marie-Tooth type 1A (CMT1A) neuropathy 123
Impairment of PMP22 transgenic Schwann cells differentiation in culture: implications for Charcot-Marie-Tooth type 1A disease. 122
An Italian family with Ala-47 transthyretin mutation associated with cardiomyopathy and polyneuropathy. 122
Levodopa-induced neutropenia. 122
PMP22 transgenic dorsal root ganglia cultures show myelin abnormalities similar to those of human CMT1A. 121
The D355V mutation decreases EGR2 binding to an element within the Cx32 promoter. 121
A nationwide retrospective analysis on the effect of immune therapies in patients with chronic inflammatory demyelinating polyradiculoneuropathy 121
Insulin treatment enhances expression of IGF-I in sural nerves of diabetic patients. 121
A cross-sectional study investigating frequency and features of definitely diagnosed diabetic painful polyneuropathy 121
Rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a report of 13 cases and review of the literature. 120
Dopamine-agonist responsive Parkinsonism in a patient with the SANDO syndrome caused by POLG mutation. 119
An abnormal mRNA produced by a novel PMP22 splice site mutation associated with HNPP 119
Responsiveness of clinical outcome measures in Charcot-Marie-Tooth disease 119
Deficiency of hyccin, a newly identified membrane protein, causes hypomyelination and congenital cataract 119
B-cell-activating factor in rituximab-treated patients with anti-MAG polyneuropathy. 118
Hand Rehabilitation Treatment for Charcot-Marie-Tooth Disease: An Open Label Pilot Study 118
WERNICKE-KORSAKOFF ENCEPHALOPATHY FOLLOWING BILIOPANCREATIC DIVERSION 118
Sjögren’s syndrome associated chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) treated with autologous and subsequently allogeneic haematopoietic SCT (HSCT) 117
Correlation between clinical/neurophysiological findings and quality of life in Charcot-Marie-Tooth type 1A. 117
Molecular diagnosis of hereditary neuropathy with liability to pressure palsies (HNPP) by detection of 17p11.2 deletion in Italian patients. 117
Multifocal motor neuropathy with conduction block after Campylobacter jejuni enteritis. 116
Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area 116
Takotsubo cardiomyopathy and torsade de pointes in myasthenic crisis: be aware of QT prolongation 116
Bannwarth syndrome: report of two cases 115
Long-term effect of rituximab in anti-mag polyneuropathy 115
Acute axonal form of Guillain-Barre syndrome in a multiple sclerosis patient: chance association or linked disorders? 115
Influence of comorbidities on the phenotype of patients affected by Charcot–Marie–Tooth neuropathy type 1A 115
Guillain-Barré syndrome following chickenpox: A case series 115
GDAP1 mutation in autosomal recessive Charcot-Marie-Tooth with pyramidal features. 114
Different cellular and molecular mechanisms for early and late-onset myelin protein zero mutations 113
Gain of glycosylation: a new pathomechanism of Myelin Protein Zero mutations 113
AN IN VITRO MODEL OF MYELIN PROTEIN ZERO MUTATIONS IN SCHWANN CELLS 113
Sonography of the median nerve in Charcot-Marie-Tooth disease 113
Innovative quantitative testing of hand function in Charcot-Marie-Tooth neuropathy 113
Randomised controlled trial of methotrexate for chronic inflammatory demyelinating polyradiculoneuropathy (RMC trial): a pilot, multicentre study. 113
Progressive multifocal leukoencephalopathy in an adult patient with ICF syndrome 112
Peripheral nerve abnormalities 112
Inherited Peripheral Neuropathies 112
Severe neuropathy after Diphtheria-Tetanus-Pertussis vaccination in a child carrying a novel frame-shift mutation in the small haet-shock protein 27 gene (HSPB1). 112
GDAP1 mutations in Italian axonal Charcot-Marie-Tooth patients: Phenotypic features and clinical course 111
Synaptopodin and 4 novel genes identified in primary sensory neurons. 111
Use of cosH1 probe in hereditary neuropathy with liability to pressure palsies: a reliable genetic test for demonstration of identical size of 17p11.2 deletion in unrelated patients. 110
Alternative Splicing in the Human PMP22 Gene: Implications in CMT1A Neuropathy 110
The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings. 110
Peripheral neuropathy in Cockayne syndrome. 110
mRNA distribution in adult human brain of GRIN2B, a N-methyl-D-aspartate (NMDA) receptor subunit. 109
Rituximab efficacy in CIDP associated with idiopathic thrombocytopenic purpura 109
Rasch-Transformed Total Neuropathy Score clinical version (RT-TNSc©) in patients with chemotherapy-induced peripheral neuropathy 109
Mitichondrial dysfunction in experimental Charcot-marie-Tooth type 1° (CMTIA) neuropathy: a possible key factor for the axonal degeneration 108
Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2. 108
Which endoneurial microvessel histologic measurements are least influenced by vasomotor tone? 108
Both Schwann cell and axonal defects cause motor peripheral neuropathy in Ebf2-/- mice. 108
Psychological considerations in the assessment and treatment of pain in neurorehabilitation and psychological factors predictive of therapeutic response: Evidence and recommendations from the Italian consensus conference on pain in neurorehabilitation 108
Is overwork weakness relevant in Charcot-Marie-Tooth disease? 108
Mutation update for myelin protein zero-related neuropathies and the increasing role of variants causing a late-onset phenotype 108
Soluble Neuregulin1 is strongly up-regulated in the rat model of Charcot-Marie-Tooth 1A disease 108
Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20) 108
Correspondence between neurophysiological and clinical measurements of chemotherapy-induced peripheral neuropathy: secondary analysis of data from the CI-PeriNomS study 107
Principles of pathology and nerve biopsy 107
A case of secondary syphilis presenting as optic neuritis 107
Impaired expression of ciliary neurotrophic factor in Charcot-Marie-Tooth type 1A neuropathy 107
A novel mutation in the N-terminal acting-binding domain of Filamin C protein causing a distal myofibrillar myopathy 107
Totale 12.100
Salva come PNG Salva come JPEG
Categoria #
all - tutte 77.644
article - articoli 72.394
book - libri 0
conference - conferenze 4.770
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 480
Totale 155.288
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.098 0 0 0 0 0 0 0 0 0 0 604 494
2019/20207.360 260 170 263 440 673 856 1.257 581 703 1.164 714 279
2020/20212.346 166 205 194 285 122 174 208 224 195 252 158 163
2021/20223.635 121 259 308 425 131 207 202 826 188 331 134 503
2022/20233.735 370 338 37 380 612 628 28 247 622 28 389 56
2023/20241.963 129 263 93 328 171 417 214 163 115 68 2 0
Totale 26.185